Rainov NG - Search Results

1

Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.

Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR 4th, Chiocca A, Breakefield XO. Rainov NG, et al. Cancer Gene Ther. 1996 Mar-Apr;3(2):99-106. Cancer Gene Ther. 1996. PMID: 8729908

2

Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector.

Rainov NG, Dobberstein KU, Heidecke V, Dorant U, Chase M, Kramm CM, Chiocca EA, Breakefield XO. Rainov NG, et al. Cancer Gene Ther. 1998 May-Jun;5(3):158-62. Cancer Gene Ther. 1998. PMID: 9622099

3

New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.

Rainov NG, Dobberstein KU, Sena-Esteves M, Herrlinger U, Kramm CM, Philpot RM, Hilton J, Chiocca EA, Breakefield XO. Rainov NG, et al. Hum Gene Ther. 1998 Jun 10;9(9):1261-73. doi: 10.1089/hum.1998.9.9-1261. Hum Gene Ther. 1998. PMID: 9650611

4

Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms.

Rainov NG, Ikeda K, Qureshi NH, Grover S, Herrlinger U, Pechan P, Chiocca EA, Breakefield XO, Barnett FH. Rainov NG, et al. Hum Gene Ther. 1999 Jan 20;10(2):311-8. doi: 10.1089/10430349950019093. Hum Gene Ther. 1999. PMID: 10022555

5

Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7.

Barnett FH, Rainov NG, Ikeda K, Schuback DE, Elliott P, Kramm CM, Chase M, Qureshi NH, Harsh G 4th, Chiocca EA, Breakefield XO. Barnett FH, et al. Among authors: rainov ng. Cancer Gene Ther. 1999 Jan-Feb;6(1):14-20. doi: 10.1038/sj.cgt.7700003. Cancer Gene Ther. 1999. PMID: 10078959

6

Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.

Herrlinger U, Woiciechowski C, Sena-Esteves M, Aboody KS, Jacobs AH, Rainov NG, Snyder EY, Breakefield XO. Herrlinger U, et al. Among authors: rainov ng. Mol Ther. 2000 Apr;1(4):347-57. doi: 10.1006/mthe.2000.0046. Mol Ther. 2000. PMID: 10933953 Free article.

7

Quantitation of HSV mass distribution in a rodent brain tumor model.

Schellingerhout D, Rainov NG, Breakefield XO, Weissleder R. Schellingerhout D, et al. Among authors: rainov ng. Gene Ther. 2000 Oct;7(19):1648-55. doi: 10.1038/sj.gt.3301272. Gene Ther. 2000. PMID: 11083473

8

Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.

Rainov NG, Fels C, Droege JW, Schäfer C, Kramm CM, Chou TC. Rainov NG, et al. Cancer Gene Ther. 2001 Sep;8(9):662-8. doi: 10.1038/sj.cgt.7700355. Cancer Gene Ther. 2001. PMID: 11593335

9

Vector delivery methods and targeting strategies for gene therapy of brain tumors.

Rainov NG, Kramm CM. Rainov NG, et al. Curr Gene Ther. 2001 Nov;1(4):367-83. doi: 10.2174/1566523013348445. Curr Gene Ther. 2001. PMID: 12109063 Review.

10

Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms.

Rainov NG, Zimmer C, Chase M, Kramm CM, Chiocca EA, Weissleder R, Breakefield XO. Rainov NG, et al. Hum Gene Ther. 1995 Dec;6(12):1543-52. doi: 10.1089/hum.1995.6.12-1543. Hum Gene Ther. 1995. PMID: 8664379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters